Researchers developed an artificial intelligence-based framework that could offer a fast and cost-effective way to repurpose drugs as treatments for Alzheimer's disease, according to a report in Nature Communications. The Drug Repurposing in Alzheimer's Disease, or DRIAD, also may help scientists analyze proteins that are targeted by Alzheimer's treatments with the most potential, and whether there are common trends in these targets.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.